The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates

Journal of Tropical Pediatrics

Volumn 53, Issue 1, 2007, Pages 22-26

  Howidi, Mohammad ^a   Rajah, Jaishen ^a   Abushrar, Ziad ^b   Parsons, Howard ^a  

^a SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BUDESONIDE; INFUSION FLUID; OXYGEN; SALBUTAMOL; STEROID;

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; CHILD HOSPITALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUID THERAPY; HUMAN; INFANT; INFANT DISEASE; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MULTIPLE REGRESSION; NEWBORN; OXYGEN THERAPY; PREMATURITY; PRESCHOOL CHILD; RANK SUM TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNITED ARAB EMIRATES; VIRAL BRONCHIOLITIS; VIRUS PNEUMONIA;

BRONCHIOLITIS, VIRAL; CHI-SQUARE DISTRIBUTION; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; OXIMETRY; OXYGEN INHALATION THERAPY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; UNITED ARAB EMIRATES;

EID: 33846690244     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fml045     Document Type: Article

References (27)

1. Toni D, Terry Y. Respiratory syncytial virus. Pediatr Rev 1998;19:55-61.
2. Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalization, 1997 to 1999. Pediatr Infect Dis J 2002;21:629-32.
3. Boyce TG, Mellen BG, Mitchel EF, Jr et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid, J Pediatr 2000;137:865-70.
4. Simoes EA. Respiratory Syncytial virus infections. Lancet 1999;354:847-52.
5. Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-6.
6. Werno AM, Anderson TP, Jenning LC, et al. Human metapneumovirus in children with bronchiolitis or pneumonia in New Zealand. J Pediatr Child Health 2004;40:549-51.
7. Esper F, Boucher D, Weibel C, et al. Human metapneumovirus infection in the United States, clinical manifestation associated with a newly emerging respiratory infection in children. Pediatrics 2003;111:1407-10.
8. Bastien N, Ward D, Van Caseele P, et al. Human metapneumovirus infection in the Canadian population. J Clin Microbiol 2003;41:4642-6.
9. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 1992;121:348-54.
10. Wang EE, Law J, Boucher FD. Other members of the Pediatric Investigators Collaborative Network in Infections in Canada Study Group. Pediatric Investigators Collaborative Network in Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1996;129:390-5.
11. Cunningham CK, McMillan JA, Gross SJ. Rehospitalization for respiratory illness of less than 32 wks' gestation. Pediatrics 1991;88:527-32.
12. Groothuis JR. Treatment and prevention of severe respiratory syncytial virus infection in young children. Curr Opin Infect Disease 1995;8:206-8.
13. Groothuis JR, Gutierrrez KM, Lauer BA. Respiratory syncytial virus infection in children with broncho-pulmonary dysplasia. Pediatrics 1988;82:199-203.
14. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Eng J Med 1986;315:77-81.
15. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in children with congenital heart disease. N Eng J Med 1982;307:397-400.
16. Meert K, Heidmann S, Abella B, et al. Does prematurity alter the course of respiratory syncytial virus infection? Crit Care Med 1990;18:1357-9.
17. Darville T, Yamauchi T. Respiratory syncytial virus. Pediatr Rev 1998;19:55-61.
18. Glezen WP, Paredes A, Allison JE, et al. Risk of RSV infection from low income families in relationship to age, sex, ethnic group, and maternal antibodies. J Pediatr 1981;98:708-15.
19. Lamprecht CL, Klause HE, Mufson MA. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis 1976;134:211-7.
20. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995;126:1004-7.
21. Garrison M, Christakis DA, Harvey E, et al. Systemic steroids in infant bronchiolitis; a meta-analysis. Pediatrics 2000,105:E44.
22. Pala P, Bjarnason R, Sigurbergsson F, et al. Enhanced IL-4 responses in children with history of RSV bronchiolitis in infancy. Eur Respir J 2002;20:376-82.
23. Strannegard O, Cello J, Bjarnason R, et al. Association between pronounced IGA response in RSV bronchiolitis and development of allergic sensitization. Pediatr Allergy Immunol 1997;8:1-6.
24. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after RSV bronchiolitis a prospective cohort study with matched controls. Pediatrics 1995;95:500-5.
25. Fishaut M, Tubergen D, McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr 1980;96:179-86.
26. Graham BS, Bunton LA, Wright PF, et al. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with RSV in mice. J Clin Invest 1991;88:1026-33.
27. Graham BS. Immunological determinants of disease caused by respiratory syncytial virus. Trends microbiol 1996;4:290-3.